Rationale and results of correction of cognitive dysfunction in patients with chronic heart failure and a reduced left ventricular ejection fraction using a combination of meldonium and gamma-butyrobetaine

Journal Title: Серце і судини - Year 2018, Vol 0, Issue 4

Abstract

The aim — to evaluate the effect of the innovative combination of meltedonium and γ‑butyrobetaine (GBB) on the state of cognitive function, quality of life and endothelial function in patients with chronic heart failure (CHF) and reduced left ventricular ejection fraction (LV EF). Materials and methods. We examined 24 patients with stable CHF and reduced LV EF (< 40 %) of the II — III functional class according to NYHA not older than 75 years who had cognitive impairments identified using standardized testing. All patients underwent general clinical examination using standard methods of psychological testing (Mini‑Mental State Examination (MMSE), Schulte tests, HADS scale, Minnesota Living with Heart Failure Questionnaire (MLHFQ), self‑assessment by patients of household physical activity using the Duke University questionnaire), ultrasound diagnosis of the vasodilating function of the endothelium of the brachial artery (VDFE BA) using a test with reactive hyperemia. The combination of meldonium with GBB was administered in a dose of 2 capsules three times a day (every 8 hours) for 4 weeks. Results and discussion. After treatment with a combination of meldonium and GBB, we observed a statistically significant improvement in cognitive function indicators on the MMSE scale (p < 0.001), Schulte test (p < 0.001), as well as the quality of life by MLHFQ (p = 0.02). While taking the drug, a significant improvement of the endothelium‑dependent vasodilatory response was observed (p < 0.001). No statistically significant effect of the combination of meldonium and GBB on the level of anxiety (HADS‑A scale) and depression (HADS‑D) was observed. Conclusions. Administration to patients with CHF and decreased LV EF of a fixed combination of meldonium and GBB for 4 weeks in addition to standard basic treatment (angiotensin‑converting enzyme inhibitor, b‑blocker, mineralcorticoid receptor antagonist, diuretic) was associated with a statistically significant improvement in cognitive tests results (total score by MMSE, Schulte test run time), quality of life by MLHFQ and significant improvement in VDFE BA according to the test with reactive hyperemia.

Authors and Affiliations

L.  G. Voronkov, A.  S. Solonovych, A.  V. Liashenko

Keywords

Related Articles

Acute myocardial infarction in patients with diabetes mellitus: possibility and expediency of cardioprotection

The aim — to evaluate the efficacy and safety of addition of a solution containing 4.2 g of arginine hydrochloride and 2.0 g L‑carnitine to standard therapy of patients with acute coronary syndrome (ACS) with ST segment...

Prevention of cardiac events in perioperative period in patients with acute calculous cholecystitis and coronary heart disease

The aim — to evaluate the effectiveness of the advanced therapy for the prevention of cardiac complications in the pre­, intra­ and early postoperative period in patients with acute calculous cholecystitis (ACC) and coro...

Influence of correction of secondary hyperparathyroidism on the pulse wave indicators and mineral density of bone tissue in middle‑aged women with uncomplicated arterial hypertension

The aim — to assess the effect of correction of secondary hyperparathyroidism on the background of deficiency and insufficiency of 25 (OH) vitamin D on the parameters of central blood pressure (BP) and pulse wave, bone m...

Risk factors for complications during recanalization of chronic coronary artery occlusions in patients with coronary artery disease

The aim — to analyze the risk factors for periprocedural complications during recanalization of chronic coronary artery (CA) occlusions in patients with coronary artery disease. Materials and methods. The study included...

Pulmonary artery sling: diagnosis and surgical treatment

The aim — to study the experience in surgical treatment of isolated and associated pulmonary artery sling including tracheal, cardiac and aortic arch anomalies, to analyze the treatment strategy, complications and their...

Download PDF file
  • EP ID EP451277
  • DOI 10.30978/HV2018-4-62
  • Views 95
  • Downloads 0

How To Cite

L.  G. Voronkov, A.  S. Solonovych, A.  V. Liashenko (2018). Rationale and results of correction of cognitive dysfunction in patients with chronic heart failure and a reduced left ventricular ejection fraction using a combination of meldonium and gamma-butyrobetaine. Серце і судини, 0(4), 62-67. https://europub.co.uk/articles/-A-451277